购物车
400-168-0010
【国际标准】 Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process
本网站 发布时间：
2025-01-16
开通会员免费在线看70000余条国内标准，赠送文本下载次数，单本最低仅合13.3元！还可享标准出版进度查询、定制跟踪推送、标准查新等超多特权！
查看详情>>
标准简介适用范围：
暂无
标准号：
ISO 10993-18:2020 EN
标准名称：
Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process
英文名称：
Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process标准状态：
现行-
发布日期：
2020-01-13 -
实施日期：
出版语种：
EN
- 其它标准
- 上一篇： ISO 10993-18:2005 EN 017172ea Biological evaluation of medical devices — Part 18: Chemical characterization of materials
- 下一篇： ISO 10993-18:2020/Amd 1:2022 EN cd2ee34d Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process — Amendment 1: Determination of the uncertainty factor
- 推荐标准
- ISO 10993-10:2021 EN 413c9289 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
- ISO 10993-12:2021 EN 5e177304 Biological evaluation of medical devices — Part 12: Sample preparation and reference materials
- ISO 10993-14:2001 EN ce434a96 Biological evaluation of medical devices — Part 14: Identification and quantification of degradation products from ceramics
- ISO 10993-16:2017 EN 38ed29c1 Biological evaluation of medical devices — Part 16: Toxicokinetic study design for degradation products and leachables
- ISO 10993-2:2022 EN c3f97179 Biological evaluation of medical devices — Part 2: Animal welfare requirements
- ISO 10993-3:2014 EN 425b441a Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- ISO 10993-4:2017/Amd 1:2025 EN 0703da00 Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood — Amendment 1
- ISO 10993-5:2009 EN 6c223ab3 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- ISO 10993-6:2016 EN fe81a910 Biological evaluation of medical devices — Part 6: Tests for local effects after implantation
- ISO 10993-7:2008/Amd 1:2019 EN c85c0ba8 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals — Amendment 1: Applicability of allowable limits for neonates and infants
- ISO 13022:2012 EN c8942a05 Medical products containing viable human cells — Application of risk management and requirements for processing practices
- ISO/TR 10993-33:2015 EN 6f7b2c13 Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3
- ISO/TR 21582:2021 EN 9bf5667f Pyrogenicity — Principles and methods for pyrogen testing of medical devices
- ISO/TR 22442-4:2010 EN 2bd3cadb Medical devices utilizing animal tissues and their derivatives — Part 4: Principles for elimination and/or inactivation of transmissible spongiform encephalopathy (TSE) agents and validation assays for those processes
- ISO/TS 10993-20:2006 EN 8615a9d6 Biological evaluation of medical devices — Part 20: Principles and methods for immunotoxicology testing of medical devices
